Six Injections of Modified Adjuvanted <scp>PQ</scp> Grass Is Effective and Well‐Tolerated in a Pivotal Phase <scp>III</scp> Trial

This pivotal Phase III trial demonstrated a significant and clinically meaningful effect on the primary endpoint as well as highly consistent secondary endpoint results and a supportive safety profile.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-02-04
DOI
https://doi.org/10.1111/all.16491
Citations
10
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
16.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial

Stefan Zielen, Ralph Mösges, Markus W. Ollert, Oliver Pfaar et al.
10 citations
Allergy
Allergic Rhinitis and Sensitization
16.22
article

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial

Stefan Zielen, Ralph Mösges, Markus W. Ollert, Oliver Pfaar, Murray Skinner, Ludger Klimek, Matthias Krämer, Markus Berger, Gunter J. Sturm, Marek Jutel, Pieter‐Jan de Kam, Mohamed H. Shamji, Uwe Edwin Berger, Janice A. Layhadi, L. DuBuske, Jonathan A. Bernstein
article en
10 citations

Abstract

This pivotal Phase III trial demonstrated a significant and clinically meaningful effect on the primary endpoint as well as highly consistent secondary endpoint results and a supportive safety profile.

AllergyVol. 80(7)
Sigmund Freud Privatuniversität Wien (AT), Goethe University Frankfurt (DE), George Washington University Hospital (US), Philipps University of Marburg (DE), University of Cologne (DE), Universität Innsbruck (AT), Medical University of Graz (AT), Odense University Hospital (DK), Wroclaw Medical University (PL), Luxembourg Institute of Health (LU), NIHR Imperial Biomedical Research Centre (GB), Bernstein Clinical Research Center (US), Wiener Krankenanstaltenverbund (AT), Zentrum für Rhinologie und Allergologie (DE), Allergy Therapeutics (United Kingdom) (GB), Allergiezentrum Wien West (AT), Imperial College London (GB), University of Cincinnati Medical Center (US)
Allergy Therapeutics
Good health and well-being
Openalex Percentile: Top 1%
Allergic Rhinitis and Sensitization
16.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.